Dual-Drug Nanostructured Lipid Carriers of Spironolactone and 2-Deoxy-D-Ribose for Targeted Follicular Delivery in Androgenetic Alopecia

    Pritam Kayal, Manoj Kumar Mishra, N. Jawahar
    Image of study
    TLDR Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.
    The study investigates dual-drug nanostructured lipid carriers containing spironolactone and 2-deoxy-D-ribose for targeted delivery to hair follicles in treating androgenetic alopecia. This approach aims to enhance treatment efficacy by improving drug delivery directly to affected areas, highlighting the potential of nanocarrier-based systems to provide a more effective solution for hair loss. Specific details on study size or outcomes are not provided.
    Discuss this study in the Community →

    Research cited in this study

    29 / 29 results